MOHAMMED T IJAZ

Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism ZANESVILLE, OH NPI 1124189592

General Payments — all program years on this page

$66,707.77

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 175
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $531.00 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $498.7318
Education $32.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Insulet Corporation $336.4216
Acerta Pharma LLC $125.001
DEXCOM, INC. $37.311
Novo Nordisk AS $32.271

By program year

Program yearAmountRecords
2018 $19,778.0948
2019 $18,588.9660
2020 $11,443.9624
2021 $3,801.167
2022 $6,088.769
2023 $6,475.848
2024 $531.0019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096594972 Novo Nordisk Inc $32.27 03/05/2024 Education Undisputed 01/23/2026 View at CMS
1105565464 AstraZeneca Pharmaceuticals LP $125.00 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796777 Insulet Corporation $15.06 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796793 Insulet Corporation $10.49 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796805 Insulet Corporation $15.91 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796823 Insulet Corporation $17.44 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796845 Insulet Corporation $10.35 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796865 Insulet Corporation $15.00 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796883 Insulet Corporation $11.76 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796901 Insulet Corporation $12.00 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796921 Insulet Corporation $12.74 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796941 Insulet Corporation $15.04 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796961 Insulet Corporation $12.85 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116796983 Insulet Corporation $12.53 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116797001 Insulet Corporation $12.28 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116816545 Insulet Corporation $119.50 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116827300 Insulet Corporation $25.26 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116827322 Insulet Corporation $18.21 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153323670 Dexcom, Inc. $37.31 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.